World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

CHALLENGES AND ETHICAL CONCERNS IN CONDUCTING CLINICAL TRIALS IN LOW AND MID-INCOME COUNTRIES: AN OVERVIEW

*Dr. Pankaj A. Mandale, MBBS, MPH, DPB.

ABSTRACT

Clinical trials are vital in drug improvement and worldwide to assess varied populations. Today, scientific trials are massive and tightly regulated. Pharmaceutical organisations have to comply with moral requirements while keeping excessive epistemic standards. The lower and middle-income communities (LMIC) countries may be a lucrative destinations for clinical trials. People dwelling in such impoverished communities have limited healthcare support and economic constraints, thus inclining them to participate in the dangerous clinical practice compared to people from developed countries. Therefore, the ethical concern of proper awareness and benefits may be compromised. They may not ask or claim the benefits of participating in the clinical trial in situations of side effects or unforeseen outcomes that debilitate their health or well-being. While the centre of attention is on the moral or ethical medical trial implementation during the research development phase, there has to be an emphasis on monitoring the concern and welfare of the participants throughout the study. This article provides insights on several challenges and problems in conducting a clinical trial in LMIC and necessitating the essential monitoring obligations to make the trails safe and in the overall interest of humanity. Challenges beyond patient participation, monitoring, overlapping responsibilities, and lack of standards and safety measures. This article also tries to make an honest attempt to oversee some of these serious issues, challenges and ethical concerns in patients participating in the clinical trials from LMIC.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR